A
Aimmune Therapeutics Inc.
AIMTHealth Care· Brisbane, California, United States
LAYOFFS TRACKED
1
LAST EVENT
Feb 10, 2023
MARKET CAP
—
EMPLOYEES
300
Aimmune Therapeutics, Inc. was a biopharmaceutical company focused on the development and commercialization of treatments for food allergies, primarily peanut allergy. Its lead product, Palforzia, is an oral immunotherapy intended to mitigate allergic reactions to peanuts through controlled exposure.
Layoff timeline
1 EVENTStories from here
No one has shared a story from Aimmune Therapeutics yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →Get alerts for Aimmune Therapeutics
We'll email you the moment a new layoff is reported here.